NO20040280L - Anvendelse av tiazolderivater for fremstilling av et medikament for beskyttelse av mitokondrier - Google Patents

Anvendelse av tiazolderivater for fremstilling av et medikament for beskyttelse av mitokondrier

Info

Publication number: NO20040280L
Authority: NO; Norway
Prior art keywords: sup; hydrogen atom; alkyl; independently represent; mitochondria
Prior art date: 2001-07-26

Application number

NO20040280A

Other languages

English (en)

Other versions

NO334797B1 (no

Inventor

De Lassauniere Pierre-Etienne Chabrier

Michel Auguet

Jeremiah Harnett

Original Assignee

Ipsen Pharma Sas

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-07-26

Filing date

2004-01-21

Publication date

2004-01-21

2004-01-21 Application filed by Ipsen Pharma Sas filed Critical Ipsen Pharma Sas

2004-01-21 Publication of NO20040280L publication Critical patent/NO20040280L/no

2014-05-26 Publication of NO334797B1 publication Critical patent/NO334797B1/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Cardiology (AREA)
Neurosurgery (AREA)
Toxicology (AREA)
Hospice & Palliative Care (AREA)
Heart & Thoracic Surgery (AREA)
Oncology (AREA)
Orthopedic Medicine & Surgery (AREA)
Ophthalmology & Optometry (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Communicable Diseases (AREA)
Physical Education & Sports Medicine (AREA)
Urology & Nephrology (AREA)
Gastroenterology & Hepatology (AREA)
Psychiatry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Thiazole And Isothizaole Compounds (AREA)
Saccharide Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Detergent Compositions (AREA)
Accessory Of Washing/Drying Machine, Commercial Washing/Drying Machine, Other Washing/Drying Machine (AREA)
Cleaning By Liquid Or Steam (AREA)

NO20040280A 2001-07-26 2004-01-21 Anvendelse av tiazolderivater for fremstilling av et medikament for beskyttelse av mitokondrier NO334797B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR0109979A FR2827772B1 (fr)	2001-07-26	2001-07-26	Utilisation de derives de thiazoles pour preparer un medicament destine a proteger les mitochondries
PCT/FR2002/002660 WO2003009843A1 (fr)	2001-07-26	2002-07-25	Utilisation de derives de thiazoles pour preparer un medicament destine a proteger les mithochondries

Publications (2)

Publication Number	Publication Date
NO20040280L true NO20040280L (no)	2004-01-21
NO334797B1 NO334797B1 (no)	2014-05-26

Family

ID=8865922

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20040280A NO334797B1 (no)	2001-07-26	2004-01-21	Anvendelse av tiazolderivater for fremstilling av et medikament for beskyttelse av mitokondrier

Country Status (25)

Country	Link
US (3)	US7345066B2 (no)
EP (1)	EP1414447B1 (no)
JP (1)	JP4491229B2 (no)
KR (1)	KR20040030843A (no)
CN (1)	CN1533276B (no)
AT (1)	ATE333876T1 (no)
AU (1)	AU2002341008B8 (no)
BR (1)	BR0211423A (no)
CA (1)	CA2455635C (no)
CY (1)	CY1106212T1 (no)
DE (1)	DE60213424T2 (no)
DK (1)	DK1414447T3 (no)
ES (1)	ES2268099T3 (no)
FR (1)	FR2827772B1 (no)
HU (2)	HU228783B1 (no)
IL (2)	IL159548A0 (no)
IS (1)	IS2366B (no)
MX (1)	MXPA04000752A (no)
NO (1)	NO334797B1 (no)
NZ (1)	NZ530368A (no)
PL (1)	PL206706B1 (no)
PT (1)	PT1414447E (no)
RU (1)	RU2297832C2 (no)
TW (1)	TWI309568B (no)
WO (1)	WO2003009843A1 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7291641B2 (en) *	1999-10-11	2007-11-06	Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.)	Derivatives of heterocycles with 5 members, their preparation and their use as medicaments
US7101917B2 (en)	2003-04-14	2006-09-05	Hoffmann-La Roche Inc.	Mitochrondrial permeability transition pore affinity labels and modulators
DE602007010821D1 (de) *	2006-10-24	2011-01-05	Congenia S R L	Phenyl-substituierte maleimide als medikamente zur hemmung von degenerativen gewebeschäden durch hemmung von mpt
KR100970814B1 (ko) *	2009-06-01	2010-07-16	주식회사 동아지질	석션 드레인 공법에 사용되는 배수재 연결구
JP6958860B2 (ja)	2017-11-07	2021-11-02	学校法人自治医科大学	ミトコンドリアの機能障害の改善剤、及びミトコンドリアの機能障害に起因する疾患又は症状の予防又は治療薬、並びにそれらの用途

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4914207A (en) *	1989-05-09	1990-04-03	Pfizer Inc.	Arylthiazolylimidazoles
EP0550631B1 (en) *	1990-09-25	1997-01-02	Rhone-Poulenc Rorer International (Holdings) Inc.	Compounds having antihypertensive and anti-ischemic properties
HU9502843D0 (en) *	1995-09-29	1995-11-28	Livigene Ltd	Pharmaceutical composition
FR2764889B1 (fr) *	1997-06-20	2000-09-01	Sod Conseils Rech Applic	Nouveaux derives du 2-(iminomethyl)amino-phenyle, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant
EP1009758B1 (en) *	1997-08-29	2005-06-01	Tularik Limited	Meta-benzamidine derivatives as serine protease inhibitors
US6518292B1 (en) *	1999-03-12	2003-02-11	Bristol-Myers Squibb Co.	Heterocyclic aromatic compounds usefuls as growth hormone secretagogues
CA2375920A1 (en) *	1999-06-14	2000-12-21	Eli Lilly And Company	Compounds
CA2381215A1 (en) *	1999-08-06	2001-02-15	Takeda Chemical Industries, Ltd.	P38map kinase inhibitors
TWI292316B (en) *	1999-10-11	2008-01-11	Sod Conseils Rech Applic	Pharmaceutical composition of thiazole derivatives intended to inhibit mao and/or lipidic peroxidation and/or to act as modulators of sodium channels and the use thereof
FR2800615B1 (fr) *	1999-11-05	2002-05-03	Sod Conseils Rech Applic	Produit comprenant au moins une substance inhibitrice des no synthases en association avec au moins une substance inhibitrice des phospholipases a2

2000
- 2000-07-13 HU HU0500484A patent/HU228783B1/hu unknown
2001
- 2001-07-26 FR FR0109979A patent/FR2827772B1/fr not_active Expired - Lifetime
2002
- 2002-07-18 TW TW091116026A patent/TWI309568B/zh not_active IP Right Cessation
- 2002-07-25 CN CN028145097A patent/CN1533276B/zh not_active Expired - Fee Related
- 2002-07-25 KR KR10-2004-7000996A patent/KR20040030843A/ko not_active Ceased
- 2002-07-25 HU HU0500557A patent/HU229425B1/hu not_active IP Right Cessation
- 2002-07-25 AT AT02774830T patent/ATE333876T1/de active
- 2002-07-25 WO PCT/FR2002/002660 patent/WO2003009843A1/fr not_active Ceased
- 2002-07-25 NZ NZ530368A patent/NZ530368A/en not_active IP Right Cessation
- 2002-07-25 DE DE60213424T patent/DE60213424T2/de not_active Expired - Lifetime
- 2002-07-25 IL IL15954802A patent/IL159548A0/xx unknown
- 2002-07-25 ES ES02774830T patent/ES2268099T3/es not_active Expired - Lifetime
- 2002-07-25 EP EP02774830A patent/EP1414447B1/fr not_active Expired - Lifetime
- 2002-07-25 PL PL368315A patent/PL206706B1/pl unknown
- 2002-07-25 DK DK02774830T patent/DK1414447T3/da active
- 2002-07-25 PT PT02774830T patent/PT1414447E/pt unknown
- 2002-07-25 RU RU2004105653/15A patent/RU2297832C2/ru not_active IP Right Cessation
- 2002-07-25 US US10/483,823 patent/US7345066B2/en not_active Expired - Fee Related
- 2002-07-25 MX MXPA04000752A patent/MXPA04000752A/es active IP Right Grant
- 2002-07-25 AU AU2002341008A patent/AU2002341008B8/en not_active Ceased
- 2002-07-25 CA CA2455635A patent/CA2455635C/fr not_active Expired - Fee Related
- 2002-07-25 BR BR0211423-2A patent/BR0211423A/pt not_active Application Discontinuation
- 2002-07-25 JP JP2003515236A patent/JP4491229B2/ja not_active Expired - Fee Related
2003
- 2003-12-24 IL IL159548A patent/IL159548A/en not_active IP Right Cessation
2004
- 2004-01-09 IS IS7100A patent/IS2366B/is unknown
- 2004-01-21 NO NO20040280A patent/NO334797B1/no not_active IP Right Cessation
2006
- 2006-10-23 CY CY20061101513T patent/CY1106212T1/el unknown
2007
- 2007-02-20 US US11/708,526 patent/US20070185174A1/en not_active Abandoned
- 2007-08-16 US US11/894,004 patent/US20080039451A1/en not_active Abandoned

Also Published As

Publication number	Publication date
PT1414447E (pt)	2006-12-29
AU2002341008B2 (en)	2007-03-08
AU2002341008A1 (en)	2003-02-17
DE60213424D1 (de)	2006-09-07
HU229425B1 (en)	2013-12-30
DE60213424T2 (de)	2007-08-23
PL368315A1 (en)	2005-03-21
CA2455635A1 (fr)	2003-02-06
DK1414447T3 (da)	2006-11-27
HUP0500484A3 (en)	2005-09-28
BR0211423A (pt)	2004-08-17
TWI309568B (en)	2009-05-11
US20070185174A1 (en)	2007-08-09
HU228783B1 (en)	2013-05-28
HU0500484D0 (en)	2005-07-28
CN1533276B (zh)	2010-06-30
ATE333876T1 (de)	2006-08-15
NO334797B1 (no)	2014-05-26
FR2827772A1 (fr)	2003-01-31
IL159548A (en)	2009-11-18
RU2004105653A (ru)	2005-04-10
IS7100A (is)	2004-01-09
AU2002341008B8 (en)	2007-08-09
CN1533276A (zh)	2004-09-29
US7345066B2 (en)	2008-03-18
US20080039451A1 (en)	2008-02-14
HUP0500557A3 (en)	2006-02-28
IS2366B (is)	2008-06-15
CY1106212T1 (el)	2011-06-08
EP1414447B1 (fr)	2006-07-26
ES2268099T3 (es)	2007-03-16
CA2455635C (fr)	2011-05-31
NZ530368A (en)	2005-04-29
HK1069326A1 (en)	2005-05-20
EP1414447A1 (fr)	2004-05-06
MXPA04000752A (es)	2004-04-20
HUP0500557A2 (hu)	2005-09-28
IL159548A0 (en)	2004-06-01
KR20040030843A (ko)	2004-04-09
JP2005500337A (ja)	2005-01-06
JP4491229B2 (ja)	2010-06-30
RU2297832C2 (ru)	2007-04-27
PL206706B1 (pl)	2010-09-30
US20040248885A1 (en)	2004-12-09
FR2827772B1 (fr)	2006-04-28
WO2003009843A1 (fr)	2003-02-06

Publication	Publication Date	Title
HUP0303037A2 (hu)	2004-03-01	Alzheimer-kór kezelésére alkalmas vegyületek és ezeket tartalmazó gyógyszerkészítmények
DK1389617T3 (da)	2007-05-07	Heterocyclisk forbindelse og antitumormiddel indeholdende denne som den aktive bestanddel
DK1054874T3 (da)	2002-12-30	Substituerede aminophenylisoxazolinderivater, der er anvendelige som antimokrobielle midler
NO20013379L (no)	2001-07-06	4-okso-1,4-dihydro-3-kinolinkarboksamider som antivirusmidler
HUP0400206A2 (hu)	2004-08-30	Metalloproteináz inhibitor hatású imidazolidin-dion-származékok, ezek alkalmazása gyógyszerkészítmények előállítására és ezeket tartalmazó gyógyszerkészítmények
AR020032A1 (es)	2002-03-27	Derivados de 1,3 -metil eritromicina.
MX9602850A (es)	1997-06-28	Derivados de pirrolopiridazina.
NO304379B1 (no)	1998-12-07	11,21-bisfenyl-19-norpregnan-derivater, anvendelse derav og farmas°ytiske preparater inneholdende slike derivater
CY1111909T1 (el)	2015-11-04	Παραγωγα [[2-(αμινο-3,4-διοξο-1-κυκλοβουτεν-1-υλ)amino] αλκυλ]-οξεος για τη θεραπεια του πονου
DE602005027213D1 (de)	2011-05-12	Neue imidazolidinderivate
TR200103349T2 (tr)	2002-05-21	Purin türevleri, hazırlama usulü ve bunları içeren ispençiyari bileşimleri.
DK1454903T3 (da)	2010-11-22	Thiadiazolinderivater til behandling af cancer
ATE374750T1 (de)	2007-10-15	Serotoninwiederaufnahme-inhibitoren
NO20040280L (no)	2004-01-21	Anvendelse av tiazolderivater for fremstilling av et medikament for beskyttelse av mitokondrier
ES2184467T3 (es)	2003-04-01	Derivados de la piperacina para la inhibicion de la replicacion del virus de la inmunodeficiencia humana.
ATE243213T1 (de)	2003-07-15	Silizium-enthaltende ascorbinsäurederivate
DK0604186T3 (da)	1997-06-16	HIV-proteaseinhibitorer, som er egnede til behandling af AIDS
ATE242229T1 (de)	2003-06-15	Kosmetische photoschutzzusammenstellungen enthaltende aminoamidine derivate und verwendungen
ES2084120T3 (es)	1996-05-01	Medicamentos para prevenir y tratar enfermedades del aparato circulatorio que contienen compuestos de espiro-3-heteroazolidina.
BG106156A (en)	2002-05-31	Aminoalkyl substituted (benzodioxan, benzofuran or benzopyran) derivatives
DE60144246D1 (de)	2011-04-28	Imidazolderivate, verfahren zu deren herstellung und deren verwendung
MXPA04000371A (es)	2004-05-04	6- (2-tolil) - triazolopirimidinas substituidas.
CO5210951A1 (es)	2002-10-30	Mezclas fungicidas sinergicas de una azolopirimidina y una fenoxiamida inhibidora de la biosisntesis de melanina
CY1113801T1 (el)	2016-07-27	Παραγωγο κιναζολινης και φαρμακευτικο ειδος
TW200508211A (en)	2005-03-01	2-naphthylimino-1,3-thiazine derivatives

Legal Events

Date	Code	Title	Description
2014-03-24	CHAD	Change of the owner's name or address (par. 44 patent law, par. patentforskriften)	Owner name: IPSEN PHARMA SAS, FR
2019-02-25	MM1K	Lapsed by not paying the annual fees